We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
78 hedge funds and large institutions have $1.46B invested in Denali Therapeutics in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
245% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 11
138% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 8
53% more capital invested
Capital invested by funds: $949M → $1.46B (+$507M)
16% more funds holding
Funds holding: 67 → 78 (+11)
4.77% more ownership
Funds ownership: 65.87% → 70.64% (+4.8%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
78
Holders Change
+11
Holders Change %
+16.42%
% of All Funds
1.78%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
19
Increased
38
Reduced
11
Closed
8
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$186K
Top Buyers
| 1 |
BlackRock
New York
|
+$36.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.5M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$12.6M |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.89M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.32M |
Top Sellers
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$28.9M |
| 2 |
AI
Alphabet Inc
Mountain View,
California
|
-$8.18M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.39M |
| 4 |
Millennium Management
New York
|
-$2.62M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$753K |
